Detalhe da pesquisa
1.
Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer.
Med Mol Morphol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619618
2.
Identification of MicroRNAs Associated with Histological Grade in Early-Stage Invasive Breast Cancer.
Int J Mol Sci
; 25(1)2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38203206
3.
Oncological safety of immediate breast reconstruction with skin- or nipple-sparing mastectomy: the value of tumor-to-dermis distance measured by preoperative ultrasonography.
World J Surg Oncol
; 19(1): 72, 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712034
4.
Computer-assisted image analysis of cytological specimens clarify the correlation between nuclear size and intranuclear cytoplasmic inclusions regardless of BRAFV600E mutation in papillary thyroid carcinoma.
Cytopathology
; 32(6): 718-731, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159645
5.
Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
Breast Cancer Res
; 22(1): 85, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32782013
6.
Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.
Breast Cancer Res Treat
; 179(3): 557-564, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31707510
7.
FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer.
Breast Cancer Res Treat
; 181(2): 331-338, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253685
8.
Phase II study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer.
BMC Cancer
; 20(1): 1068, 2020 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158432
9.
Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
J Appl Clin Med Phys
; 21(4): 42-50, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32150329
10.
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
Br J Cancer
; 120(12): 1129-1136, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31114020
11.
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Breast Cancer Res Treat
; 176(1): 63-73, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30941650
12.
ß2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.
Breast Cancer Res Treat
; 177(3): 603-610, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290053
13.
Comparing protein and mRNA expressions of the human epidermal growth factor receptor family in estrogen receptor-positive breast cancer.
Med Mol Morphol
; 52(2): 90-98, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259117
14.
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
Breast Cancer Res Treat
; 172(1): 61-68, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30056565
15.
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
Breast Cancer Res Treat
; 170(3): 525-533, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633055
16.
Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3.
J Hum Genet
; 63(12): 1197-1210, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228364
17.
Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer.
Med Mol Morphol
; 50(4): 185-194, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28936553
18.
Establishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay.
Cancer Sci
; 107(3): 341-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26716425
19.
Control of primary lesions using resection or radiotherapy can improve the prognosis of metastatic colorectal cancer patients.
J Surg Oncol
; 114(1): 75-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27111137
20.
KPNA2 over-expression is a potential marker of prognosis and therapeutic sensitivity in colorectal cancer patients.
J Surg Oncol
; 113(2): 213-7, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26663089